Vitrolife
92.55 SEK
-1.54 %
Less than 1K followers
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 197.50 | 215.80 | 560.00 | 186.20 | 194.70 | 215.00 | 137.00 |
| Shares | 108.6 | 108.6 | 114.7 | 135.4 | 135.4 | 135.4 | 135.4 |
| Market cap | 21,438.6 | 23,425.1 | 64,204.6 | 25,220.3 | 26,371.6 | 29,121.1 | 18,556.3 |
| Enterprise value | 20,749.1 | 22,451.5 | 65,947.5 | 26,867.3 | 27,599.6 | 30,075.1 | - |
| EV/S | 14.0 | 18.0 | 39.2 | 8.3 | 7.9 | 8.3 | - |
| EV/EBITDA | 39.1 | 56.9 | 145.2 | 36.7 | neg. | 31.3 | - |
| EV/EBIT | 42.5 | 60.7 | 151.5 | 41.1 | neg. | 38.4 | - |
| P/E | 56.0 | 81.7 | 188.3 | 64.0 | neg. | 56.7 | neg. |
| P/B | 11.93 | 11.61 | 4.19 | 1.51 | 2.07 | 2.13 | 2.35 |
| P/S | 14.5 | 18.8 | 38.2 | 7.8 | 7.5 | 8.1 | 5.4 |
| Dividend yield | 0.5 % | 0.4 % | 0.1 % | 0.5 % | 0.5 % | 0.5 % | 0.8 % |
| Equity ratio | 84.1 % | 87.5 % | 79.0 % | 81.5 % | 77.9 % | 78.2 % | 71.0 % |
| Gearing ratio | 4.2 % | 3.1 % | 15.5 % | 13.3 % | 16.4 % | 15.3 % | 20.3 % |